The move is the latest effort to peel back the curtain on the interplay between pharmaceutical manufacturers and various organizations, some of which have been accused of working harder on behalf of industry interests than patient concerns. Other news on the crisis deals with kratom and needle exchanges.

from Kaiser Health News https://ift.tt/2RPcz1D

Related Posts:

0 comments:

Post a Comment

Popular Posts